Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
暂无分享,去创建一个
Y. Mahjoub | M. Guilbart | H. Dupont | P. Guinot | F. Juthier | N. Rousse | A. Vincentelli | E. Robin | P. Besserve | T. Caus | O. Abou-Arab | P. Huette | C. Decoene | C. Beyls | Antoine Lamer | M. Moussa | G. Leroy | J. Meynier | Stefan Roksic | Vincent Petitgand | C. Dupré | Céline Dupré
[1] A. Kimmoun,et al. Optimizing PO2 during peripheral veno-arterial ECMO: a narrative review , 2022, Critical Care.
[2] F. Juthier,et al. Subclavian versus femoral arterial cannulations during extracorporeal membrane oxygenation: A propensity-matched comparison. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] J. Laffey,et al. Dangers of hyperoxia , 2021, Critical Care.
[4] T. Lange,et al. Lower versus higher oxygenation targets in critically ill patients with severe hypoxaemia: secondary Bayesian analysis to explore heterogeneous treatment effects in the Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) trial , 2021, British journal of anaesthesia.
[5] L. Rasmussen,et al. Determining a safe upper limit of oxygen supplementation for adult patients: a systematic review , 2021, BMJ Open.
[6] R. Geocadin,et al. Duration of Hyperoxia and Neurologic Outcomes in Patients Undergoing Extracorporeal Membrane Oxygenation , 2021, Critical care medicine.
[7] S. Susen,et al. Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study , 2021, Journal of clinical medicine.
[8] J. Bazin,et al. French legal approach to patient consent in clinical research. , 2020, Anaesthesia, critical care & pain medicine.
[9] R. Bellomo,et al. Conservative oxygen therapy for mechanically ventilated adults with suspected hypoxic ischaemic encephalopathy , 2020, Intensive Care Medicine.
[10] M. Guilbart,et al. Hyperoxia during cardiopulmonary bypass does not increase respiratory or neurological complications: a post hoc analysis of the CARDIOX study. , 2020, British journal of anaesthesia.
[11] R. Attou,et al. Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site? , 2020, Critical Care.
[12] J. Fraser,et al. The effect of hyperoxia on inflammation and platelet responses in an ex vivo extracorporeal membrane oxygenation circuit. , 2020, Artificial organs.
[13] A. Burrell,et al. Hyperoxia in patients with cardiogenic shock after myocardial infarction supported with venoarterial extracorporeal membrane oxygenation. , 2020, Australian Critical Care.
[14] T. Staudinger,et al. Feasibility and safety of watershed detection by contrast-enhanced ultrasound in patients receiving peripheral venoarterial extracorporeal membrane oxygenation: a prospective observational study , 2020, Critical Care.
[15] B. Souweine,et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. , 2020, The New England journal of medicine.
[16] R. Bellomo,et al. Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. , 2020, The New England journal of medicine.
[17] F. Gao,et al. Prognostic Factors for Survival After Extracorporeal Membrane Oxygenation for Cardiogenic Shock , 2020, ASAIO journal.
[18] R. Bellomo,et al. Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX) , 2019, Intensive Care Medicine.
[19] L. Martineau,et al. Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial , 2019, Intensive Care Medicine.
[20] M. Tung,et al. Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice , 2019, Molecular Imaging and Biology.
[21] J. Ornato,et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[22] T. Major,et al. Differential Effects of Normoxic and Hyperoxic Reperfusion on Global Myocardial Ischemia-Reperfusion Injury. , 2019, Seminars in thoracic and cardiovascular surgery.
[23] J. Jeudy,et al. Harlequin Syndrome during Venoarterial Extracorporeal Membrane Oxygenation. , 2019, Radiology. Cardiothoracic imaging.
[24] R. Berg,et al. Hyperoxia and Hypocapnia During Pediatric Extracorporeal Membrane Oxygenation: Associations With Complications, Mortality, and Functional Status Among Survivors* , 2018, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[25] N. Shime,et al. Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support? , 2018, Critical care medicine.
[26] A. Kiss,et al. Oxygen Thresholds and Mortality During Extracorporeal Life Support in Adult Patients* , 2017, Critical care medicine.
[27] Lang Li,et al. [Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation]. , 2017, Zhonghua wei zhong bing ji jiu yi xue.
[28] E. Ohman,et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.
[29] R. Thiagarajan,et al. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry , 2017, Critical Care.
[30] M. Bailey,et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation , 2016, Annals of Intensive Care.
[31] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[32] M. Singer,et al. The medical use of oxygen: a time for critical reappraisal , 2013, Journal of internal medicine.
[33] Karen Ulisney,et al. INTERMACS profiles of advanced heart failure: the current picture. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[35] H. S,et al. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .
[36] C. Stolar,et al. Differential effects of alveolar and arterial oxygen tension on pulmonary vasomotor tone in ECMO-perfused, isolated piglet lungs. , 1991, Journal of pediatric surgery.
[37] D. Rubin. INFERENCE AND MISSING DATA , 1975 .